The Norwegian Cancer Society’s (NCS) aim is to prevent and fight cancer, and to ensure the best quality of life for patients and their families. Through research, prevention, information, support, advice, and lobbying, we fight cancer locally, nationally and globally. The NCS provides a considerable amount of all direct funding for cancer research in Norway, thus contributing to promoting a research environment of top international standard in the country. Furthermore, nurturing innovation and promoting novel ideas play a crucial role in advancing cancer research and enhancing patient outcomes.

Research findings frequently serve as the foundation for multiple potential commercial applications. In a qualification project, the primary objective is to thoroughly explore and pinpoint the most promising commercial application prospects, including service innovation. This initial investigation lays the groundwork for subsequent technology verification and development. Promising research and innovative solutions often take too long to reach patients. The NCS aims to accelerate this process, particularly for those applications with high patient benefit. This call focus on increasing the innovation potential of projects funded by the NCS (from 2016-2023).

https://nettsoknad.kreftforeningen.no/#call/1622/details